BT5528是一款靶向EphA2的双环肽偶联毒素。EphA2在多种难...查看全文
牛唐2021-10-08 10:23
医药板块速评(2021.10.07)
本期内容提示:
1、RLAY数据在即,如何看待AI选药概念股?
2、ALLO的实验被叫停,对基因编辑板块影响如何?
3、第一大仓位BCYC数据不错,已实现150%+的收益,谁是下一个BCYC?
$Relay Therapeutics(RLAY)$ $Intellia(NTLA)$ $Bicycle治疗(BCYC)$查看全文
产业链观察2021-07-14 16:46
药闻| 2021年7月13日,基于其专有的双环肽 ( Bicycle® ) 技术开创了一种新型差异化疗法的生物技术公司$Bicycle治疗(BCYC)$ )宣布Ionis Pharmaceuticals 已行使其选择权并签订了一项全球独家许可和合作协议,使用对转铁蛋白受体 (TfR1) 具有高亲和力的双环肽进行寡核苷酸治疗(#RNAi疗...查看全文
chuminhua2021-07-14 11:40
7月13日,生物技术公司Bicycle Therapeutics plc(纳斯达克:BCYC),在其专利的双环肽(Bicycle®)技术的基础上开创了一种新的、差异化的治疗方法,今天宣布,Ionis制药公司已行使其选择权,并签订了独家的全球许可和合作协议, 使用与转铁蛋白受体 (TfR1) 具有高亲和力的 Bicycle:reg...查看全文
Takeabreak2021-05-11 23:46
$Bicycle治疗(BCYC)$ BCYC Bicycle Therapeutics price target raised to $44 from $38 at Oppenheimer查看全文
Takeabreak2021-03-12 11:25
$Bicycle治疗(BCYC)$ 重起升势,会前先看30
网页链接{Bicycle Therapeutics to Present at the Oppenheimer 31st Annual Healthcare Conference | Bic...查看全文
丰硕创投2021-03-12 10:23
2763字3图,阅读大约需要6分钟。
文章首发于丰硕创投,欢迎朋友圈与微信转发。
公众号及其它平台转载请后台留言。
PDC药物正处于ADC药物当年起飞的时间节点上,但市场还未认识到它的价值,PDC能否引爆偶联药物,让我们拭目以待。
1.PDC药物简介
2.竞争格局
3.PDC药物临床...查看全文
$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000168 Act: 33 Size: 4 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000169 Act: 33 Size: 4 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000170 Act: 33 Size: 5 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000164 Act: 33 Size: 4 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000165 Act: 33 Size: 4 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000166 Act: 33 Size: 4 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000167 Act: 33 Size: 4 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-075569 Size: 29 KB 网页链接
$Bicycle Therapeutics(BCYC)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001761612-24-000003 Act: 33 Size: 20 KB 网页链接
$Bicycle Therapeutics(BCYC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-069660 Act: 34 Size: 91 KB 网页链接